188 related articles for article (PubMed ID: 35722277)
1. The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases.
Li Y; Lin X; Wang W; Wang W; Cheng S; Huang Y; Zou Y; Ke J; Zhu L
Front Microbiol; 2022; 13():926915. PubMed ID: 35722277
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Guanylate-binding protein 5-mediated cell-autonomous immunity suppresses inflammation in dental pulpitis: An in vitro study.
Huang M; Zhan C; Yang B; Lu Y; Yang X; Hou J
Int Endod J; 2024 Feb; 57(2):208-218. PubMed ID: 38050666
[TBL] [Abstract][Full Text] [Related]
4. The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans.
Liu L; Dong Y; Ye M; Jin S; Yang J; Joosse ME; Sun Y; Zhang J; Lazarev M; Brant SR; Safar B; Marohn M; Mezey E; Li X
J Crohns Colitis; 2017 Jun; 11(6):737-750. PubMed ID: 27993998
[TBL] [Abstract][Full Text] [Related]
5. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory bowel diseases and inflammasome].
Kim JM
Korean J Gastroenterol; 2011 Dec; 58(6):300-10. PubMed ID: 22198227
[TBL] [Abstract][Full Text] [Related]
7. IBD Subtype-Regulators
Gao S; Li Y; Wu D; Jiao N; Yang L; Zhao R; Xu Z; Chen W; Lin X; Cheng S; Zhu L; Lan P; Zhu R
Front Pharmacol; 2022; 13():869200. PubMed ID: 35462887
[No Abstract] [Full Text] [Related]
8. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
9. GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
Li Z; Qu X; Liu X; Huan C; Wang H; Zhao Z; Yang X; Hua S; Zhang W
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796072
[TBL] [Abstract][Full Text] [Related]
10. Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection.
Feng J; Cao Z; Wang L; Wan Y; Peng N; Wang Q; Chen X; Zhou Y; Zhu Y
J Innate Immun; 2017; 9(4):419-435. PubMed ID: 28376501
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice.
Wu G; Zhang D; Yang L; Wu Q; Yuan L
Mol Immunol; 2022 Jun; 146():57-68. PubMed ID: 35447415
[TBL] [Abstract][Full Text] [Related]
12. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.
Bauer C; Duewell P; Mayer C; Lehr HA; Fitzgerald KA; Dauer M; Tschopp J; Endres S; Latz E; Schnurr M
Gut; 2010 Sep; 59(9):1192-9. PubMed ID: 20442201
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
14. Roseburia intestinalis‑derived flagellin ameliorates colitis by targeting miR‑223‑3p‑mediated activation of NLRP3 inflammasome and pyroptosis.
Wu X; Pan S; Luo W; Shen Z; Meng X; Xiao M; Tan B; Nie K; Tong T; Wang X
Mol Med Rep; 2020 Oct; 22(4):2695-2704. PubMed ID: 32700754
[TBL] [Abstract][Full Text] [Related]
15. Wip 1 inhibits intestinal inflammation in inflammatory bowel disease.
Zhang Q; Zhang C; Chang F; Liang K; Yin X; Li X; Zhao K; Niu Q; Tian Z
Cell Immunol; 2016 Dec; 310():63-70. PubMed ID: 27687530
[TBL] [Abstract][Full Text] [Related]
16. [NLRP3 inflammasome as causative and protecting factor in pathogenesis of inflammatory bowel diseases].
Świerczyński M; Fichna J
Postepy Biochem; 2021 Mar; 67(1):44-53. PubMed ID: 34378904
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
[TBL] [Abstract][Full Text] [Related]
18. Expression Levels of Proinflammatory Cytokines and NLRP3 Inflammasome in an Experimental Model of Oxazolone-induced Colitis.
Zherebiatiev A; Kamyshnyi A
Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):39-45. PubMed ID: 26996110
[TBL] [Abstract][Full Text] [Related]
19. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.
Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ
Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease.
Ricanek P; Lunde LK; Frye SA; Støen M; Nygård S; Morth JP; Rydning A; Vatn MH; Amiry-Moghaddam M; Tønjum T
Clin Exp Gastroenterol; 2015; 8():49-67. PubMed ID: 25624769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
